Amneal to Report Second Quarter 2022 Results on August 5, 2022
July 08 2022 - 7:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that
the Company will release its second quarter 2022 financial results
on Friday August 5, 2022, prior to market open. The Company will
host a conference call and live webcast with the investment
community at 8:30 a.m. Eastern Time on August 5, 2022.
The financial results and live webcast will be accessible
through the Investor Relations section of the Company's website at
https://investors.amneal.com.
To access the call through a conference line, dial 1 (844)
200-6205 (in the U.S.) or 1 (929) 526-1599 (international callers).
The access code for the call is 236256.
A replay of the conference call will be posted shortly after the
call and will be available for seven days. To access the replay,
dial 1 (866) 813-9403 (in the U.S.) or +44 (204) 525-0658
(international callers). The access code for the replay is
862075.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in
Bridgewater, NJ, is a fully integrated essential medicines company.
We make healthy possible through the development, manufacturing,
and distribution of generic and specialty pharmaceuticals,
primarily within the United States. The Company has a diverse
portfolio of over 250 products in its Generics segment and is
expanding across a broad range of complex products and therapeutic
areas, including injectables and biosimilars. In its Specialty
segment, Amneal has a growing portfolio of branded pharmaceutical
products focused primarily on central nervous system and endocrine
disorders, with a pipeline focused on unmet needs. Through its
AvKARE segment, the Company is a distributor of pharmaceuticals and
other products for the U.S. federal government, retail, and
institutional markets. For more, please visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220708005055/en/
Anthony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2024 to May 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From May 2023 to May 2024